Investigation for the prevalence of anti-SARS-CoV-2 antibody.

Investigation for the prevalence of anti-SARS-CoV-2 antibody. - Investigation for the prevalence of anti-SARS-CoV-2 antibody.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046246

Enrollment

400

Registered

2021-12-04

Start date

2021-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Employees of Fukuoka City Hospital who have undergone antibody testing

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The influence of post-vaccination reactions and use of antipyretic medications on the anti-SARS-CoV-2 spike antibody titer	—

Countries

Japan

Contacts

Public ContactNaoki Tani

Kyushu University Graduate School of Medical Sciences Medicine and Biosystemic Science

nao_taniyan@icloud.com+81-92-642-5229

Outcome results